0001751294-20-000001.txt : 20200818 0001751294-20-000001.hdr.sgml : 20200818 20200818170023 ACCESSION NUMBER: 0001751294-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200818 DATE AS OF CHANGE: 20200818 EFFECTIVENESS DATE: 20200818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cure, Inc. CENTRAL INDEX KEY: 0001751294 IRS NUMBER: 371867828 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373508 FILM NUMBER: 201114431 BUSINESS ADDRESS: STREET 1: 10 BARCLAY STREET #31G CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: 301-785-5255 MAIL ADDRESS: STREET 1: 10 BARCLAY STREET #31G CITY: NEW YORK STATE: NY ZIP: 10007 D 1 primary_doc.xml X0708 D LIVE 0001751294 Cure, Inc. 225 Fifth Avenue #2D New York NY NEW YORK 10010 000-000-0000 DELAWARE None None Corporation true 2017 Lauren Picasso c/o Cure, Inc. 225 Fifth Avenue #2D New York NY NEW YORK 10010 Executive Officer Director Other Decline to Disclose 06b false 2020-08-05 false true false 0 2608103 2608103 0 false 33 0 0 0 true The proceeds will be used for general working capital, which may include payments to persons listed in Item 3. false Cure, Inc. /s/ Lauren Picasso Lauren Picasso President and CEO 2020-08-18